BMJ, doi: 10.1136/bmj.38867.631551.55, (Published 12 June 2006)

RESEARCH

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

Etelka Moll ^1*, Patrick M M Bossuyt ², Johanna C Korevaar ², Cornelis B Lambalk ³, Fulco van der Veen ¹

¹ Centre for Reproductive Medicine, Department of Obstetrics and Gynaecology, Academic Medical Centre, PO Box 22700, 1100 DE, Amsterdam, Netherlands
² Clinical Epidemiology and Biostatistics, Academic Medical Centre, Amsterdam, Netherlands
³ Division of Reproductive Medicine, Department of Obstetrics and Gynaecology, Vrije Universiteit Medical Centre, PO Box 7057, 1007 MB, Amsterdam, Netherlands

^* Correspondence to: e.moll{at}amc.uva.nl.

Objective To compare the effectiveness of clomifene citrate plus metformin and clomifene citrate plus placebo in women with newly diagnosed polycystic ovary syndrome.

Design Randomised clinical trial.

Setting Multicentre trial in 20 Dutch hospitals.

Participants 228 women with polycystic ovary syndrome.

Interventions Clomifene citrate plus metformin or clomifene citrate plus placebo.

Main outcome measure The primary outcome measure was ovulation. Secondary outcome measures were ongoing pregnancy, spontaneous abortion, and clomifene resistance.

Results 111 women were allocated to clomifene citrate plus metformin (metformin group) and 114 women were allocated to clomifene citrate plus placebo (placebo group). The ovulation rate in the metformin group was 64% compared with 72% in the placebo group, a non-significant difference (risk difference -8%, 95% confidence interval -20% to 4%). There were no significant differences in either rate of ongoing pregnancy (40% v 46%; -6%, -20% to 7%) or rate of spontaneous abortion (12% v 11%; 1%, -7% to 10%). A significantly larger proportion of women in the metformin group discontinued treatment because of side effects (16% v 5%; 11%, 5% to 16%).

Conclusion Metformin is not an effective addition to clomifene citrate as the primary method of inducing ovulation in women with polycystic ovary syndrome.

Trial registration Current Controlled Trials ISRCTN55906981 [controlled-trials.com].

---

(Accepted 28 March 2006)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Managing anovulatory infertility and polycystic ovary syndrome

Adam H Balen and Anthony J Rutherford
BMJ 2007 335: 663-666. [Extract] [Full Text] [PDF]

Adding metformin doesn't increase number of ovulations in women with PCOS
BMJ 2006 332: 0. [Full Text]

Drugs for anovulatory infertility in polycystic ovary syndrome

Hesham Al-Inany and Neil Johnson
BMJ 2006 332: 1461-1462. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Moll, E., Korevaar, J.C., Bossuyt, P.M.M., van der Veen, F. (2008). Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?. Hum Reprod 23: 1830-1834 [Abstract] [Full text]  
• Creanga, A. A., Bradley, H. M., McCormick, C., Witkop, C. T. (2008). Use of Metformin in Polycystic Ovary Syndrome: A Meta-Analysis. Obstet Gynecol 111: 959-968 [Abstract] [Full text]  
• Moll, E., van der Veen, F. (2008). Reply: Metformin in therapy naive patients with polycystic ovary syndrome. Hum Reprod Update 14: 193-194 [Full text]  
• Palomba, S., Falbo, A. (2008). Metformin in therapy naive patients with polycystic ovary syndrome. Hum Reprod Update 14: 193-193 [Full text]  
• The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consens, (2008). Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23: 462-477 [Abstract] [Full text]  
• Nestler, J. E. (2008). Metformin for the Treatment of the Polycystic Ovary Syndrome. NEJM 358: 47-54 [Full text]  
• Moll, E., van der Veen, F., van Wely, M. (2007). The role of metformin in polycystic ovary syndrome: a systematic review. Hum Reprod Update 13: 527-537 [Abstract] [Full text]  
• Balen, A. H, Rutherford, A. J (2007). Managing anovulatory infertility and polycystic ovary syndrome. BMJ 335: 663-666 [Full text]  
• Shojania, K. G., Sampson, M., Ansari, M. T., Ji, J., Doucette, S., Moher, D. (2007). How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis. ANN INTERN MED 147: 224-233 [Abstract] [Full text]  
• Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., Gosman, G. G., Nestler, J. E., Giudice, L. C., Leppert, P. C., Myers, E. R., the Cooperative Multicenter Reproductive Medicine, (2007). Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome. NEJM 356: 551-566 [Abstract] [Full text]  
• Guzick, D. S. (2007). Treating the Polycystic Ovary Syndrome the Old-Fashioned Way. NEJM 356: 622-624 [Full text]  
• Legro, R. S. (2007). A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome. JAMA 297: 509-519 [Abstract] [Full text]  
• Al-Inany, H., Johnson, N. (2006). Drugs for anovulatory infertility in polycystic ovary syndrome.. BMJ 332: 1461-1462 [Full text]  

Rapid Responses:

Read all Rapid Responses

Good Work, but not the end of the PCOS/Metformin Saga.

William U Atiomo
bmj.com, 23 Jun 2006 [Full text]

Metformin still has its place.

Jeevan P Marasinghe
bmj.com, 24 Jun 2006 [Full text]

Re: Good Work, but not the end of the PCOS/Metformin Saga.

Etelka Moll, et al.
bmj.com, 28 Jun 2006 [Full text]

Re: Metformin still has its place.

Etelka Moll, et al.
bmj.com, 28 Jun 2006 [Full text]

Not All Faith In Metformin Lost

Spyros Papaioannou, et al.
bmj.com, 30 Jun 2006 [Full text]

Re: Not All Faith In Metformin Lost

Etelka Moll, et al.
bmj.com, 14 Jul 2006 [Full text]

Necessity to assess the clinical predictors for driving the best strategy of treatment in infertile anovulatory patients with polycystic ovary syndrome

Stefano Palomba, et al.
bmj.com, 1 Aug 2006 [Full text]